BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6092443)

  • 1. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The glucagonoma syndrome].
    Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
    Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucagonoma: evolution and treatment].
    Carvajal C; Azabache V; Lobos P; Ibarra A
    Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
    Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrolytic migratory erythema without glucagonoma versus canine superficial necrolytic dermatitis: is hepatic impairment a clue to pathogenesis?
    Kasper CS; McMurry K
    J Am Acad Dermatol; 1991 Sep; 25(3):534-41. PubMed ID: 1655838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis.
    Hunt SJ; Narus VT; Abell E
    J Am Acad Dermatol; 1991 Mar; 24(3):473-7. PubMed ID: 2061449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
    Tseng HC; Liu CT; Ho JC; Lin SH
    Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
    Skouge JW; Farmer ER
    Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythema necroticans migrans without glucagonoma].
    Tanner M; Brasch J; Christophers E
    Hautarzt; 1994 Jul; 45(7):480-3. PubMed ID: 7928344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucagonoma syndrome--report of a case without overt diabetes.
    Leibovici V; Granot E; Eid A; Goldin E; Okon E
    J Dermatol; 1987 Oct; 14(5):491-6. PubMed ID: 2830323
    [No Abstract]   [Full Text] [Related]  

  • 17. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
    Chang CH; Sheu HM; Cheng GS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.